Overview

Study in Chronic Kidney Disease (CKD) Not on Dialysis

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the efficacy and safety of lanthanum carbonate 750 to 2,250 mg in Japanese Chronic Kidney Disease Stage 3, 4 and 5 subjects not on dialysis.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Collaborator:
Shire